logo-loader
AIM:TRX

Tissue Regenix Group PLC

Receive alerts
Market:
AIM
Price
68.50 GBX
Day Change
-
Market Cap:
£48.34 m
52 weeks high
72.94
52 weeks low
48.00

In brief

Tissue Regenix Group PLC is a pioneering, international medical technology company, focusing on the development of regenerative products utilising its two platform technologies, dCELL, addressing soft tissue needs, and BioRinse, providing sterile bone allografts.

The company is currently helping to transform the treatment of patients in key surgical applications: biosurgery, orthopaedics (sports medicine/spine), dental, general, plastic surgery, urology/gynaecology, ophthalmology and cardiac.

Snapshot

  • Tissue Regenix dispatches allograft EU orders after Irish facility green light
  • Tissue Regenix's new hub creates 'significant opportunity' - broker
  • Tissue Regenix Group says "disciplined approach" paying off at half-year stage